Matches in Wikidata for { <http://www.wikidata.org/entity/Q93130632> ?p ?o ?g. }
- Q93130632 description "2019 nî lūn-bûn" @default.
- Q93130632 description "2019年の論文" @default.
- Q93130632 description "2019年学术文章" @default.
- Q93130632 description "2019年学术文章" @default.
- Q93130632 description "2019年学术文章" @default.
- Q93130632 description "2019年学术文章" @default.
- Q93130632 description "2019年学术文章" @default.
- Q93130632 description "2019年学术文章" @default.
- Q93130632 description "2019年學術文章" @default.
- Q93130632 description "2019年學術文章" @default.
- Q93130632 description "2019年學術文章" @default.
- Q93130632 description "2019年學術文章" @default.
- Q93130632 description "2019年學術文章" @default.
- Q93130632 description "2019년 논문" @default.
- Q93130632 description "article científic" @default.
- Q93130632 description "article scientific" @default.
- Q93130632 description "article scientifique" @default.
- Q93130632 description "articol științific" @default.
- Q93130632 description "articolo scientifico" @default.
- Q93130632 description "artigo científico" @default.
- Q93130632 description "artigo científico" @default.
- Q93130632 description "artigo científico" @default.
- Q93130632 description "artikel ilmiah" @default.
- Q93130632 description "artikull shkencor" @default.
- Q93130632 description "artikulong pang-agham" @default.
- Q93130632 description "artykuł naukowy" @default.
- Q93130632 description "artículo científico publicado en 2019" @default.
- Q93130632 description "artículu científicu" @default.
- Q93130632 description "bilimsel makale" @default.
- Q93130632 description "bài báo khoa học" @default.
- Q93130632 description "naučni članak" @default.
- Q93130632 description "scienca artikolo" @default.
- Q93130632 description "scientific article published on 13 April 2019" @default.
- Q93130632 description "scientific article published on 13 April 2019" @default.
- Q93130632 description "scientific article published on 13 April 2019" @default.
- Q93130632 description "teaduslik artikkel" @default.
- Q93130632 description "tieteellinen artikkeli" @default.
- Q93130632 description "tudományos cikk" @default.
- Q93130632 description "vedecký článok" @default.
- Q93130632 description "vetenskaplig artikel" @default.
- Q93130632 description "videnskabelig artikel udgivet 13. april 2019" @default.
- Q93130632 description "vitenskapelig artikkel" @default.
- Q93130632 description "vitskapeleg artikkel" @default.
- Q93130632 description "vědecký článek" @default.
- Q93130632 description "wetenschappelijk artikel" @default.
- Q93130632 description "wissenschaftlicher Artikel" @default.
- Q93130632 description "επιστημονικό άρθρο" @default.
- Q93130632 description "мақолаи илмӣ" @default.
- Q93130632 description "наукова стаття, опублікована у квітні 2019" @default.
- Q93130632 description "научна статия" @default.
- Q93130632 description "научная статья" @default.
- Q93130632 description "научни чланак" @default.
- Q93130632 description "научни чланак" @default.
- Q93130632 description "מאמר מדעי" @default.
- Q93130632 description "مقالة علمية نشرت في 13 أبريل 2019" @default.
- Q93130632 description "১৩ এপ্রিল ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q93130632 description "บทความทางวิทยาศาสตร์" @default.
- Q93130632 description "სამეცნიერო სტატია" @default.
- Q93130632 name "Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study" @default.
- Q93130632 name "Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study" @default.
- Q93130632 type Item @default.
- Q93130632 label "Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study" @default.
- Q93130632 label "Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study" @default.
- Q93130632 prefLabel "Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study" @default.
- Q93130632 prefLabel "Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study" @default.
- Q93130632 P1433 Q93130632-69DE2C49-1F41-4C1A-9983-18275C785EF3 @default.
- Q93130632 P1476 Q93130632-0AB29ED1-DF12-45DF-9BBF-8B3F1A7B21F1 @default.
- Q93130632 P2093 Q93130632-06049014-A0D1-4FA4-BC0E-D213175CAC0E @default.
- Q93130632 P2093 Q93130632-0FDB1EA3-2CA0-4C15-80FD-51FEC4DB9816 @default.
- Q93130632 P2093 Q93130632-116C907F-8B30-44C7-85F6-02549FFA8238 @default.
- Q93130632 P2093 Q93130632-2A1D9BC2-282D-4C8C-ACE7-C9B99E159AEF @default.
- Q93130632 P2093 Q93130632-62855C6B-8740-42C2-9437-9CCBCAEDB79B @default.
- Q93130632 P2093 Q93130632-7813549C-F082-4B0F-AAD0-0FE19E86972A @default.
- Q93130632 P2093 Q93130632-7D09BAA0-0AB2-4069-8C4F-B2A6F7C6113F @default.
- Q93130632 P2093 Q93130632-A18B4151-F40C-4CE4-8455-544E0E53CA2E @default.
- Q93130632 P2093 Q93130632-AFDB41BD-BA2A-4054-A03D-03B154CE2AC5 @default.
- Q93130632 P2093 Q93130632-D662C47A-D639-4605-8B88-44657D212AC1 @default.
- Q93130632 P2093 Q93130632-D96486B9-FB06-4666-8556-2464D5171878 @default.
- Q93130632 P2093 Q93130632-F8DBCE73-209F-44F0-AF9B-30E8AA71B353 @default.
- Q93130632 P2093 Q93130632-FA4755C7-07D2-4F8B-9214-BFE23A18B947 @default.
- Q93130632 P304 Q93130632-01AA7AB8-C8E5-4657-BE1D-02C1EDD5698B @default.
- Q93130632 P31 Q93130632-4EDED884-F3A8-4659-A574-204E2947EAD4 @default.
- Q93130632 P356 Q93130632-A3BE634E-95EB-4891-84F6-342415D3CF60 @default.
- Q93130632 P478 Q93130632-3D477FEF-F2A5-4992-882B-4B666125C99A @default.
- Q93130632 P577 Q93130632-B2FD18A4-3023-4AA3-89BF-30B47C9A0B01 @default.
- Q93130632 P698 Q93130632-D4E0D957-D68D-4BB2-945D-5B52240AACBA @default.
- Q93130632 P921 Q93130632-35D3B950-264F-4CFC-A030-E1070F48BBC5 @default.
- Q93130632 P921 Q93130632-3832FF86-EB26-4D68-A291-910B42134F54 @default.
- Q93130632 P921 Q93130632-F3510377-1EC9-4180-B1D2-F506E8FF2B48 @default.
- Q93130632 P356 J.EJCA.2019.03.012 @default.
- Q93130632 P698 30991261 @default.
- Q93130632 P1433 Q332260 @default.
- Q93130632 P1476 "Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study" @default.
- Q93130632 P2093 "Aya Kuchiba" @default.
- Q93130632 P2093 "Hidehito Horinouchi" @default.
- Q93130632 P2093 "Kenichi Nakamura" @default.
- Q93130632 P2093 "Makoto Nishio" @default.
- Q93130632 P2093 "Miyako Satouchi" @default.
- Q93130632 P2093 "Shigeki Umemura" @default.
- Q93130632 P2093 "Takashi Seto" @default.